Excimer laser technology in percutaneous coronary interventions: Cardiovascular laser society's position paper

6533b85afe1ef96bd12b95b9

RESEARCH PRODUCT

Excimer laser technology in percutaneous coronary interventions: Cardiovascular laser society's position paper

Golino L Caiazzo G Calabrò P Colombo A Contarini M Fedele F Gabrielli G Galassi A R Golino P Scotto Di Uccio F Tarantini G Argentino V Balbi M Bernardi G Boccalatte M Bonmassari R Bottiglieri G Caramanno G Cesaro F Cigala E Chizzola G Di Lorenzo E Intorcia A Fattore L Galli S Gerosa G Giannotta D Grossi P Monda V Mucaj A Napodano M Nicosia A Perrotta R Pieri D Prati F Ramazzotti V Romeo F Rubino A Russolillo E Spedicato L Tuccillo B Tumscitz C Vigna C Bertinato L Armigliato P Ambrosini V

subject

Chronic occlusion Atherectomy Coronary Technology Atherectomy Severe calcific lesion Chronic occlusions; ELCA; Laser angioplasty; Severe calcific lesions; Stent under-expansion; Thrombotic lesions; Coronary Angiography; Humans; Lasers Excimer; Technology; Treatment Outcome; Atherectomy Coronary; Percutaneous Coronary Intervention Lasers Coronary Thrombotic lesion Coronary Angiography Chronic occlusions Excimer Treatment Outcome Percutaneous Coronary Intervention Stent under-expansion Severe calcific lesions Humans Laser angioplasty Lasers Excimer ELCA Cardiology and Cardiovascular Medicine Thrombotic lesions Human

description

Excimer Laser Coronary Atherectomy (ELCA) is a well-established therapy that emerged for the treatment of peripheral vascular atherosclerosis in the late 1980s, at a time when catheters and materials were rudimentary and associated with the most serious complications. Refinements in catheter technology and the introduction of improved laser techniques have led to their effective use for the treatment of a wide spectrum of complex coronary lesions, such as thrombotic lesions, severe calcific lesions, non-crossable or non-expandable lesions, chronic occlusions, and stent under-expansion. The gradual introduction of high-energy strategies combined with the contrast infusion technique has enabled us to treat an increasing number of complex cases with a low rate of periprocedural complications. Currently, the use of the ELCA has also been demonstrated to be effective in acute coronary syndrome (ACS), especially in the context of large thrombotic lesions.

year	journal	country	edition	language
2022-01-01	International Journal of Cardiology

https://doi.org/10.1016/j.ijcard.2021.12.054